The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: A critical assessment of "oculostenotic" reintervention in patients with intermediate lesions

JACC: Cardiovascular Interventions

Volumn 3, Issue 4, 2010, Pages 403-411

  Uchida, Takahiro ^a,j   Popma, Jeffrey ^b   Stone, Gregg W ^c   Ellis, Stephen G ^d   Turco, Mark A ^e   Ormiston, John A ^f   Muramatsu, Toshiya ^g   Nakamura, Masato ^h   Nanto, Shinsgbre ⁱ   Yokoi, Hiroyoshi ^j   Baim, Donald S ^a  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e WASHINGTON ADVENTIST HOSPITAL   (United States)

^f Mercy Hospital   (United States)

^g SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^h TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

ⁱ OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j KOKURA MEMORIAL HOSPITAL   (Japan)

more..

Author keywords

drug eluting stent; intermediate lesions; meta analysis; oculostenotic reflex

Indexed keywords

PACLITAXEL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENOSIS; TREATMENT OUTCOME; AGED; CHI SQUARE DISTRIBUTION; CORONARY ARTERY OBSTRUCTION; DISEASE FREE SURVIVAL; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; INSTRUMENTATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PREDICTION AND FORECASTING; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RADIOGRAPHY; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954672985     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.01.010     Document Type: Article

References (39)

1. S.B. King III, S.C. Smith Jr., and J.W. Hirshfeld Jr. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 51 2008 172 209
2. S. Silber, P. Albertsson, and F.F. Aviles The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Guidelines for percutaneous coronary interventions Eur Heart J 26 2005 804 847
3. G.A. Beller, and B.L. Zaret Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease Circulation 101 2000 1465 1478
4. L.J. Shaw, D.S. Berman, and D.J. Maron Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
5. R.F. Davies, A.D. Goldberg, and S. Forman Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization Circulation 95 1997 2037 2043
6. P. Erne, A.W. Schoenenberger, and D. Burckhardt Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISS II randomized controlled trial JAMA 297 2007 1985 1991
7. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
8. N.H. Pijls, P. van Schaardenburgh, and G. Manoharan Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study J Am Coll Cardiol 49 2007 2105 2111
9. P.A. Tonino, B. De Bruyne, and N.H. Pijls Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
10. H.J. Rupprecht, C. Espinola-Klein, and R. Erbel Impact of routine angiographic follow-up after angioplasty Am Heart J 136 1998 613 619
11. R. West, G. Ellis, and N. Brooks Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications Heart 92 2006 810 814
12. G. Devlin, L. Lazzam, and L. Schwartz Mortality related to diagnostic cardiac catheterization The importance of left main coronary disease and catheter induced trauma Int J Card Imaging 13 1997 379 384 (Pubitemid 127509003)
13. L.W. Johnson, and R. Krone Cardiac catheterization 1991: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I) Cathet Cardiovasc Diagn 28 1993 219 220
14. R. Asano, T. Sumiyoshi, and T. Tohbaru Routine follow-up angiography is necessary after coronary intervention Circ J 67 2003 65
15. P.N. Ruygrok, R. Melkert, and M.-A.M. Morel Does angiography six months after coronary intervention influence management and outcome? J Am Coll Cardiol 34 1999 1507 1511
16. D.S. Pinto, G.W. Stone, and S.G. Ellis Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial J Am Coll Cardiol 48 2006 32 36
17. J. Lasala, D. Cox, and D. Dobies Usage patterns and 2-year outcomes with the TAXUS Express stent: results of the U.S. ARRIVE 1 registry Catheter Cardiovasc Interv 72 2008 433 445
18. J.M. ten Berg, J.C. Kelder, M.J. Suttorp, F.W.A. Verheugt, and H.W. Thijs Plokker Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study J Am Coll Cardiol 38 2001 1061 1069
19. E.J. Topol Coronary angioplasty for acute myocardial infarction Ann Intern Med 109 1988 970 980
20. E.J. Topol, and S.E. Nissen Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease Circulation 92 1995 2333 2342
21. D.E. Cutlip, M.S. Chauhan, and D.S. Baim Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials J Am Coll Cardiol 40 2002 2082 2089
22. G.W. Stone, S.G. Ellis, and D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 2004 1942 1947
23. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
24. G.W. Stone, S.G. Ellis, and L. Cannon Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial JAMA 294 2005 1215 1223
25. M.A. Turco, J.A. Ormiston, and J.J. Popma Polymer-based, paclitaxel-eluting TAXUS Libert stent in de novo lesions: the pivotal TAXUS ATLAS trial J Am Coll Cardiol 49 2007 1676 1683
26. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
27. M. Asakura, Y. Ueda, and S. Nanto Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up Circulation 97 1998 2003 2006
28. J.S. Hochman, J.E. Tamis, and T.D. Thompson Sex, clinical presentation, and outcome in patients with acute coronary syndromes Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators N Engl J Med 341 1999 226 232
29. J.A. Ormiston, F.M. Stewart, A.H. Roche, B.J. Webber, R.M. Whitlock, and M.W. Webster Late regression of the dilated site after coronary angioplasty: a 5-year quantitative angiographic study Circulation 96 1997 468 474
30. C.V. Patil, and R. Beyar Intermediate coronary artery stenosis: evidence-based decisions in interventions to avoid the oculostenotic reflex Int J Cardiovasc Intervent 3 2000 195 206
31. W.S. Weintraub, J.A. Spertus, and P. Kolm Effect of PCI on quality of life in patients with stable coronary disease N Engl J Med 359 2008 677 687
32. H. Schhlen, A. Kastrati, and J. Mehilli Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement Am Heart J 147 2004 317 322
33. N.G. Uren, J.A. Melin, B. De Bruyne, W. Wijns, T. Baudhuin, and P.G. Camici Relation between myocardial blood flow and the severity of coronary-artery stenosis N Engl J Med 330 1994 1782 1788
34. E.D. Folland, R.A. Vogel, and P. Hartigan Relation between coronary artery stenosis assessed by visual, caliper, and computer methods and exercise capacity in patients with single-vessel coronary artery disease The Veterans Affairs ACME Investigators Circulation 89 1994 2005 2014
35. M.-C. Morice, A. Colombo, and B. Meier Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial JAMA 295 2006 895 904
36. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
37. A. Kastrati, A. Dibra, and S. Eberle Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials JAMA 294 2005 819 825
38. A. Dibra, A. Kastrati, and J. Mehilli Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670
39. M.A. Turco, J.A. Ormiston, and J.J. Popma Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Libert stent: 1-year results from the TAXUS ATLAS program J Am Coll Cardiol Intv 1 2008 699 709